[VSsupport]

<img alt="" height="1" width="1" />FDA, Clinical Trial News: InterMune, Optimer and Salix PharmaBefore It's News... 550mg Tablet to expand the FDA-approved label to include the treatment of patients with non-constipation irritable bowel syndrome (non-C IBS). www. ...<nobr>and more »</nobr>

View the full article